By Susan Reckling From: ascopost.com BluePrint in combination with MammaPrint molecular subtyping reclassified more than 20% of breast cancer patients into a different subgroup compared with conventional assessment, according to the results of the prospective Neoadjuvant Breast Registry Symphony Trial (NBRST). In Annals of Surgical Oncology, Whitworth et al reported that this reclassification of patients led to an improved distribution …
Uptown Charlotte Welcomes Race for the Cure® and Chicago Bears Oct. 4-5
Fans of Carolina Panthers star running back DeAngelo Williams will be busy in uptown Charlotte the weekend of Oct. 4-5. On Saturday, Williams Warriors, inspired by Williams and his late mother Sandra Hill, will participate in the 18th Annual Susan G. Komen Charlotte Race for the Cure®. On Sunday, Oct. 5, attention will shift to Charlotte’s Bank of America Stadium as …
Cancer patients often struggle with depression without getting any professional help
By Rhodi Lee, From: techtimes.com Cancer patients do not just battle with their physical ailment. Many also suffer from clinical depression. Unfortunately, as many as three-quarters of these patients to do not receive effective treatment for their condition, researchers from Oxford and Edinburgh universities in the UK have found. For their new study published in The Lancet Psychiatry on Thursday, …
Pumping in cancer drugs
By Bradley J. Fikes From: utsandiego.com Researchers have invented a microscopic pump that has the potential to transport cancer drugs from the blood into the heart of tumors, according to a new study. The pump is created from an engineered antibody that attaches to a protein found in microscopic pouches lining the walls of blood vessels in mouse, rat and …
One Day Breast Cancer Treatment Available for Some Women, for Others a Reduction in Post Surgical Radiation Requirements
JFK Medical Center is the first hospital in the United States to perform Electron Intraoperative Radiation Therapy (e-IORT) on a new technology called Liac 12 from Sordina IORT Technologies USA, Inc. (SIT, USA.) This new procedure can essentially reduce breast cancer treatment from six and a half weeks to one day for many women. Advances in surgery and radiation therapy …
GE Healthcare Announces FDA Approval of SenoClaire, New Breast Imaging with 3D Tomosynthesis Solution
Wauwatosa, WI, September 3, 2014 — GE Healthcare (NYSE: GE) today announced the FDA approval of SenoClaire*, GE’s new breast tomosynthesis solution designed with a three-dimensional imaging technology. In collaboration with Massachusetts General Hospital, GE developed SenoClaire technology that uses a low-dose short X-ray sweep around the positioned breast with nine exposures acquired with a “step-and-shoot” method, removing the potential …
Local Dream Team Develops Cancer Treatment That’s Saving Lives
By:: Lisa Sigell From: cbslocal.com This Friday, CBS will air the annual star-studded telethon Stand Up To Cancer, which has raised millions for cancer research. That research has made possible medical discoveries that are saving lives. Health reporter Lisa Sigell shows us one such discovery here in Los Angeles. A dream team of Cal Tech and UCLA scientists and doctors …
Mayo Clinic offers at-home colon cancer screening test; critics cite concerns
By Melissa Turtinen From: bringmethenews.com Minnesota-based Mayo Clinic is offering a new at-home test that its makers claim is a reliable alternative to the dreaded colonoscopy – although critics are raising questions about the costly new “breakthrough” product. Hospital officials announced Monday they’ll be among the first in the U.S. to offer the FDA-approved Cologuard test – a take-home, stool DNA test …
Tomatoes ‘important in prostate cancer prevention’
By: Helen Briggs From: bbc.com Men who consume more than 10 portions of tomatoes each week reduce their risk by about 20%, according to a UK study. Prostate cancer is the second most common cancer in men worldwide, with 35,000 new cases and around 10,000 deaths in the UK every year. Cancer experts recommend eating a balanced diet which is …
UPDATED: Kite Pharma spikes on its second take of CAR-T cancer study
By: John Carroll From: fiercebiotech.com Kite Pharma has once again demonstrated just how hot experimental CAR-T technology is in the cancer field. The Santa Monica, CA-based biotech reported Monday evening in a trial update that 12 of 13 evaluable patients with advanced B cell malignancies demonstrated a complete or partial response after being treated with its chimeric antigen receptor (CAR) …